(Q59566187)
Statements
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase (English)
F M Sirotnak
M F Zakowski
V A Miller
1 December 2000